Both in Pharmaceuticals
Organogenesis Holdings vs Minerva Neurosciences
Over the past year ORGO returned −77.6% and NERV returned −30.0%; their daily moves had a correlation of 0.12.
ORGO −77.6% NERV −30.0%Growth of $1, one year, split-adjusted
| Metric | ORGO | NERV |
|---|---|---|
| Price | $0.8700 | $2.57 |
| Market cap | $111.9M | $122.7M |
| Today | +4.19% | +9.36% |
| 1 month | −35.1% | −25.1% |
| 6 months | −66.0% | −58.7% |
| Year to date | −83.2% | −36.1% |
| 1 year | −78.3% | −32.7% |
| Revenue growth (YoY) | −56.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −227.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.2× | — |
| Net cash | $34.4M | $75.3M |
| Dividend yield | — | — |
| Volatility (60d) | 61.2% | 79.8% |
| Short % of float | 21.7% | 6.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).